Andy Fenny

Andy Fenny has a significant amount of work experience, with their most recent position being the Chief Commercial Officer (CCO) at SK pharmteco since September 2023. Prior to that, they held several roles at FUJIFILM Diosynth Biotechnologies, including Chief Business Officer from February 2018 to September 2023. Before joining FUJIFILM Diosynth Biotechnologies, they worked at MSD Biologics as a Senior Programme Manager from February 2010 to March 2011, and at Avecia as a Senior Programme Manager from 2002 to 2010. Overall, Andy Fenny has a strong background in program management and business planning within the biotechnology and pharmaceutical industry.

Andy Fenny completed a Bachelor of Science in Cell/Cellular and Molecular Biology from The University of Huddersfield, from 1998 to 2002.